Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Idorsia Ltd

IDRSFPNK
Healthcare
Biotechnology
$5.14
$0.00(0.00%)
U.S. Market opens in NaNh NaNm

Idorsia Ltd Fundamental Analysis

Idorsia Ltd (IDRSF) shows moderate financial fundamentals with a PE ratio of -7.20, profit margin of -50.87%, and ROE of 10.24%. The company generates $0.3B in annual revenue with weak year-over-year growth of -26.17%.

Key Strengths

PEG Ratio-0.51

Areas of Concern

Operating Margin-25.30%
We analyze IDRSF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -16.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-16.9/100

We analyze IDRSF's fundamental strength across five key dimensions:

Efficiency Score

Weak

IDRSF struggles to generate sufficient returns from assets.

ROA > 10%
-26.05%

Valuation Score

Excellent

IDRSF trades at attractive valuation levels.

PE < 25
-7.20
PEG Ratio < 2
-0.51

Growth Score

Moderate

IDRSF shows steady but slowing expansion.

Revenue Growth > 5%
-26.17%
EPS Growth > 10%
13.17%

Financial Health Score

Excellent

IDRSF maintains a strong and stable balance sheet.

Debt/Equity < 1
-1.11
Current Ratio > 1
1.40

Profitability Score

Weak

IDRSF struggles to sustain strong margins.

ROE > 15%
10.24%
Net Margin ≥ 15%
-50.87%
Positive Free Cash Flow
No

Key Financial Metrics

Is IDRSF Expensive or Cheap?

P/E Ratio

IDRSF trades at -7.20 times earnings. This suggests potential undervaluation.

-7.20

PEG Ratio

When adjusting for growth, IDRSF's PEG of -0.51 indicates potential undervaluation.

-0.51

Price to Book

The market values Idorsia Ltd at -0.75 times its book value. This may indicate undervaluation.

-0.75

EV/EBITDA

Enterprise value stands at 3.15 times EBITDA. This is generally considered low.

3.15

How Well Does IDRSF Make Money?

Net Profit Margin

For every $100 in sales, Idorsia Ltd keeps $-50.87 as profit after all expenses.

-50.87%

Operating Margin

Core operations generate -25.30 in profit for every $100 in revenue, before interest and taxes.

-25.30%

ROE

Management delivers $10.24 in profit for every $100 of shareholder equity.

10.24%

ROA

Idorsia Ltd generates $-26.05 in profit for every $100 in assets, demonstrating efficient asset deployment.

-26.05%

Following the Money - Real Cash Generation

Operating Cash Flow

Idorsia Ltd generates limited operating cash flow of $-147.58M, signaling weaker underlying cash strength.

$-147.58M

Free Cash Flow

Idorsia Ltd generates weak or negative free cash flow of $-160.08M, restricting financial flexibility.

$-160.08M

FCF Per Share

Each share generates $-0.65 in free cash annually.

$-0.65

FCF Yield

IDRSF converts -14.05% of its market value into free cash.

-14.05%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-7.20

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.51

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.75

vs 25 benchmark

P/S Ratio

Price to sales ratio

4.24

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.11

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.40

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.10

vs 25 benchmark

ROA

Return on assets percentage

-0.26

vs 25 benchmark

ROCE

Return on capital employed

-0.19

vs 25 benchmark

How IDRSF Stacks Against Its Sector Peers

MetricIDRSF ValueSector AveragePerformance
P/E Ratio-7.2029.45 Better (Cheaper)
ROE10.24%779.00% Weak
Net Margin-50.87%-24936.00% (disorted) Weak
Debt/Equity-1.110.26 Strong (Low Leverage)
Current Ratio1.404.65 Neutral
ROA-26.05%-19344.00% (disorted) Weak

IDRSF outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Idorsia Ltd's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

245.23%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

61.03%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

41.43%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ